Nuritas™ to Attend 3rd Annual Advances in Immuno-Oncology Congress 2018

We are looking forward to attending the 3rd Annual Advances in Immuno-Oncology Congress 2018 in London, UK on May 24th & 25th.

“The 3rd Annual Advances in Immuno-Oncology Congress will feature over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations, and leading biotechnology companies. Over 50 presentations and case studies will focus on the key developments in immuno-oncology with specific reference to the discovery of therapeutic areas and pre-clinical and clinical studies.”

If you are in attendance and would like to arrange a meeting, please email our Director of Lifesciences at kiernan.chantelle@Nuritas.com.

For more information on the event click here.